EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression



CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression



Cytometry. Part B, Clinical Cytometry 70(3): 136-141



Increased CD38 expression by leukemic cells has been suggested as an adverse prognostic factor in B-CLL. Several approaches have been proposed to quantify its level of expression by flow cytometry. We compared the use of (i) the percentage of CD38 positive cells, (ii) CD38 antibodies bound per cell (ABC), and (iii) a semi-quantitative method based on the shape of the CD38 histogram, within a cohort of 78 B-CLL patients. A decreased overall survival was seen with >30% CD38 positivity among B-CLL cells, with CD38 ABC >100, and with bimodal or unimodal, strongly positive CD38 histograms. However, patients with unimodal weakly positive CD38 histograms also showed a significantly reduced survival as did patients with intermediate proportions (i.e. 5-30%) of CD38+ cells. Furthermore, within the group with <5% CD38 positivity among their B-CLL cells, 84% of patients showed prognostically favourable mutated IGVH gene segments and 100% had low ZAP70 gene expression. For 5-30% CD38 positivity, these proportions were 50 and 83%, while for >30% CD38 positivity, these proportion were only 28 and 56%, respectively. We found a simple method of quantitation of CD38 expression (i.e., >5% CD38 positivity among B-CLL cells) to be sufficient to identify patients with an unfavourable prognosis. The level of CD38 expression as defined with this method correlated well with the IGVH mutation status and ZAP70 gene expression.

(PDF emailed within 0-6 h: $19.90)

Accession: 048421563

Download citation: RISBibTeXText

PMID: 16568475

DOI: 10.1002/cyto.b.20106



Related references

Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia. British Journal of Haematology 118(3): 755-761, September, 2002

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia (Basingstoke) 20(10): 1774-1782, 2006

ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value. Folia Histochemica et Cytobiologica 46(2): 147-152, 2008

CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia. Leukemia Research 33(2): 237-243, 2008

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98(1): 181-186, July 1, 2001

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia 16(1): 30-35, 2002

The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia. Journal of Biological Regulators and Homeostatic Agents 18(3-4): 340-346, 2004

The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia. Journal of Biological Regulators and Homeostatic Agents 18(3-4): 340-346, 2005

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. British Journal of Haematology 116(1): 142-150, January, 2002

Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia. British Journal of Haematology 120(6): 1017-1025, March, 2003

T-cell CD38 expression in B-chronic lymphocytic leukaemia. Hematological Oncology 27(2): 82-89, 2009

The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. British Journal of Haematology 130(4): 549-557, 2005

CD38 expression and IgV gene mutations are independent prognostic factors in chronic lymphocytic leukaemia and can be used to select stage A patients for treatment. British Journal of Haematology 113(Supplement 1): 62, 2001

The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia. Annals of Oncology 17(4): 683-690, 2006

Correlation between cell size and CD38 expression in chronic lymphocytic leukaemia. Leukemia & Lymphoma 44(5): 797-800, 2003